Target intelligence / Profile preview

Clusterin-like protein 1 (CLUL1)

Target
CLUL1
Molecular classification
Other (Retina-specific secreted glycoprotein), Molecular chaperone-like protein
01

Overview

Clusterin-like protein 1 (CLUL1) is a retina-specific, secreted glycoprotein with homology to the molecular chaperone clusterin, though sharing only ~25% sequence identity. Unlike clusterin, which has broad tissue expression, CLUL1 expression is tentative to cone photoreceptor cells in the retina and is highly regulated during retinal development and photoreceptor differentiation. It undergoes light-dependent subcellular localization in cone cells and is predicted to bind misfolded proteins and function as an extracellular chaperone, supporting photoreceptor cell homeostasis and survival. Genetic studies have associated CLUL1 with retinal diseases—variants may influence susceptibility or protection against age-related macular degeneration (AMD), though clearly pathogenic or drug-responsive mutations in humans are not established. Its relevance to retinal disorders is further supported by altered expression in naturally occurring and experimental animal models of retinal degeneration. Peptides derived from CLUL1 have been proposed as potential biomarkers for diagnosing retinal and possibly systemic disease states, but these applications remain under investigation. CLUL1 is not a classic drug target, and no current therapeutics directly modulate its function. Its main significance lies in its putative role as a retinal photoreceptor chaperone and as a gene of interest in genetic association studies of retinal diseases.

Other names
Clusterin-like 1CLUL1Clusterin-like protein 1Retinal-specific clusterin-like proteinRetinal clusterin-like proteinRA337M
02

Biological functions

Photoreceptor cell homeostasis (specifically in cone cells)Misfolded protein binding (predicted)Extracellular chaperone-like activityRegulation and maintenance of cone photoreceptorsRetinal development
03

Disease associations

Retinal degeneration (as a candidate or potential biomarker)Age-related macular degeneration (AMD) (protective variant associations)High-grade myopia (studied, but no clear pathogenic mutations)
04

Biomarkers

Peptides corresponding to CLUL1 detected in serum may serve as candidate biomarkers for retinal or other disease states

Beyond the preview

Go deeper on Clusterin-like protein 1 (CLUL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clusterin-like protein 1 (CLUL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call